key: cord-0823755-v3631w0b authors: Roncati, Luca; Nasillo, Vincenzo; Lusenti, Beatrice; Riva, Giovanni title: Signals of T(h)2 immune response from COVID-19 patients requiring intensive care date: 2020-05-08 journal: Ann Hematol DOI: 10.1007/s00277-020-04066-7 sha: 9d096918bff028a1d69b458d4cdcfa59df03b14d doc_id: 823755 cord_uid: v3631w0b nan gastrointestinal symptoms present up to 30% of COVID-19 patients and significantly associated with dyspnea [5] ; in fact, hyperperistalsis and gastric fluid acidification are also two notorious default mechanisms of defense to expel parasites governed by T h 2 cytokines [1] . Conflict of interest The authors declare that they have no conflict of interest. Ethical approval All procedures followed were in accordance with the ethical standards and with the Helsinki Declaration of 1975, as revised in 2008. Informed consent Not applicable since the manuscript does not contain any patient data. Type 1 / type 2 immunity in infectious diseases Eosinophils and their interactions with respiratory virus pathogens The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality Aging enhances the basal production of IL-6 and CCL2 in vascular smooth muscle cells Clinical characteristics of SARS-CoV-2 infected pneumonia with diarrhea Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations